Literature DB >> 3096611

Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay.

M Rånby, N Bergsdorf, T Nilsson, G Mellbring, B Winblad, G Bucht.   

Abstract

A procedure for improving the specificity of enzyme-linked immunosorbent assays (ELISA) was devised, based on addition of antigen-specific or non-immune immunoglobulins to the citrated plasma sample and defining the difference in assay response between these two mixtures as the antigen-specific part of the response. When applied to measurement of tissue plasminogen activator (t-PA; EC 3.4.21.31) antigen in plasma, this procedure resulted in elimination of the overestimates obtained in a large proportion (10-20%) of patients' samples when assayed according to the conventional ELISA technique. Basal t-PA concentrations in plasma were found to be highly age-dependent, normal values being about 3 micrograms/L for adults near 30 years of age and about 10 micrograms/L for those over 60. Patients with gallbladder stone disease had increased mass concentrations of t-PA in plasma, even when corrected for the age effect; patients with multi-infarct dementia did not.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096611

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.

Authors:  J H Jansson; B Johansson; K Boman; T K Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  The pharmacokinetics and absorption of recombinant human relaxin in nonpregnant rabbits and rhesus monkeys after intravenous and intravaginal administration.

Authors:  S A Chen; B Reed; T Nguyen; N Gaylord; G B Fuller; J Mordenti
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

Review 4.  Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients.

Authors:  M T Nurmohamed; H R Büller; J W ten Cate
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

5.  Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors.

Authors:  J O Clausen; K Borch-Johnsen; H Ibsen; R N Bergman; P Hougaard; K Winther; O Pedersen
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

6.  Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study.

Authors:  G H Tofler; J Massaro; C J O'Donnell; P W F Wilson; R S Vasan; P A Sutherland; J B Meigs; D Levy; R B D'Agostino
Journal:  Thromb Res       Date:  2016-02-03       Impact factor: 3.944

7.  Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes.

Authors:  A Kirk; N Mutrie; P MacIntyre; M Fisher
Journal:  Diabetologia       Date:  2004-05-11       Impact factor: 10.122

8.  Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.

Authors:  O C Gebara; M A Mittleman; B W Walsh; I Lipinska; F K Welty; G Bellotti; J E Muller; F K Sacks; G H Tofler
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

9.  The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration.

Authors:  S A Chen; A J Perlman; N Spanski; C M Peterson; S W Sanders; R Jaffe; M Martin; T Yalcinkaya; R C Cefalo; N C Chescheir
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

10.  The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase.

Authors:  Johan B Nilsson; Kurt Boman; Jan-Håkan Jansson; Torbjörn Nilsson; Ulf Näslund
Journal:  J Thromb Thrombolysis       Date:  2007-08-25       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.